Ptc Therapeutics reported $406.24M in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 125.63M 9.06M
Alnylam Pharmaceuticals ALNY:US USD 767.92M 4.88M
Amgen AMGN:US USD 15.69B 1.36B
Biogen BIIB:US USD 3.27B 653.6M
Biomarin Pharmaceutical BMRN:US USD 588.88M 67.86M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Cytokinetics CYTK:US USD 84.62M 8.12M
Daiichi Sankyo 4568:JP JPY 457.07B 28.97B
Enanta Pharmaceuticals ENTA:US USD 23M 6.83M
Esperion Therapeutics ESPR:US USD 92.31M 9.96M
Gilead Sciences GILD:US USD 11.24B 814M
Intercept Pharmaceuticals ICPT:US USD 230.08M 8.49M
Ironwood Pharmaceuticals IRWD:US USD 25.52M 1.59M
Karyopharm Therapeutics KPTI:US USD 72M 10.24M
Novartis NOVN:VX USD 28.66B 496M
Ptc Therapeutics PTCT:US USD 406.24M 13.84M
Puma Biotechnology PBYI:US USD 77.48M 17.5M
Roche Holding ROG:VX 27.24B 170M
Sangamo Biosciences SGMO:US USD 111.71M 10.65M
Sarepta Therapeutics SRPT:US USD 619.6M 16.69M
Tg Therapeutics TGTX:US USD 53.2M 16.75M
Ultragenyx Pharmaceutical RARE:US USD 261.21M 33.85M
Vertex Pharmaceuticals VRTX:US USD 2.43B 178.7M
Xencor XNCR:US USD 63.84M 26.19M
YTE INCY:US USD 1.16B 150.48M